Haptoglobin is a glycoprotein which is synthesized in the liver and circulates in the blood. Haptoglobin is produced typically by hepatocytes but also by other tissues: e.g. skin, lung, and kidney. It is a positive acute phase protein that binds free hemoglobin and removes it from the circulation to prevent kidney injury, and iron loss following hemolysis. The haptoglobin- hemoglobin complex is subsequently removed by the reticuloendothelial system (generally the spleen). As the reticuloendothelial system removes the haptoglobin-hemoglobin complex from the body, haptoglobin levels are reduced in hemolytic anaemias. In the course of binding hemoglobin, haptoglobin sequesters the iron inside hemoglobin, preventing iron-utilizing bacteria from benefitting from hemolysis.
Source:Recombinant protein corresponding to aa145-405 from human Haptoglobin, fused to His-tag, expressed in E. coli.
Molecular Weight:~33kD (~4kD His-tag)
Applications:Suitable for use as Positive Control for Western Blot, Antibody Production and Protein Assays. Other applications not tested.
Recommended Dilution:Optimal dilutions to be determined by the researcher.
Storage and Stability:Lyophilized powder may be stored at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
Size:5ug
Source Antigen:Recombinant, E. coli
Grade:Purified
Purity:~90% (SDS-PAGE, HPLC)
Form:Supplied as a lyophilized powder in PBS, 0.1% SDS, 1mM DTT. Reconstitute with sterile ddH2O >100ug/ml.